Sandbox/v31: Difference between revisions
< Sandbox
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
Line 4: | Line 4: | ||
{{CMG}}; {{AE}} {{CZ}}, {{SS}} | {{CMG}}; {{AE}} {{CZ}}, {{SS}} | ||
==Empiric Therapy== | ==Empiric Therapy <SMALL><SMALL><SMALL><SMALL><SMALL>Adapted from ''Advances in treatment of bacterial meningitis. Lancet. 2012;380(9854):1693-702.''<ref name="van de Beek-2012">{{Cite journal | last1 = van de Beek | first1 = D. | last2 = Brouwer | first2 = MC. | last3 = Thwaites | first3 = GE. | last4 = Tunkel | first4 = AR. | title = Advances in treatment of bacterial meningitis. | journal = Lancet | volume = 380 | issue = 9854 | pages = 1693-702 | month = Nov | year = 2012 | doi = 10.1016/S0140-6736(12)61186-6 | PMID = 23141618 }}</ref></SMALL></SMALL></SMALL></SMALL></SMALL>== | ||
{| | |||
| valign=top | | |||
<BIG><BIG>'''Community-Acquired Meningitis'''</BIG></BIG> | <BIG><BIG>'''Community-Acquired Meningitis'''</BIG></BIG> | ||
<div class="mw-customtoggle-table01" style="width: 300px; background: #F8F8FF; border: 2px solid #696969; border-bottom: 0px"> ▸ <font color="# | <div class="mw-customtoggle-table01" style="width: 300px; background: #F8F8FF; border: 2px solid #696969; border-bottom: 0px"> ▸ <font color="#1F4099">'''Newborn, Age <1 Week'''</font></div> | ||
<div class="mw-customtoggle-table02" style="width: 300px; background: #F8F8FF; border: 2px solid #696969; border-bottom: 0px"> ▸ <font color="# | <div class="mw-customtoggle-table02" style="width: 300px; background: #F8F8FF; border: 2px solid #696969; border-bottom: 0px"> ▸ <font color="#1F4099">'''Newborn, Age 1—4 Weeks'''</font></div> | ||
<div class="mw-customtoggle-table03" style="width: 300px; background: #F8F8FF; border: 2px solid #696969; border-bottom: 0px"> ▸ <font color="# | <div class="mw-customtoggle-table03" style="width: 300px; background: #F8F8FF; border: 2px solid #696969; border-bottom: 0px"> ▸ <font color="#1F4099">'''Infant & Children'''</font></div> | ||
<div class="mw-customtoggle-table04" style="width: 300px; background: #F8F8FF; border: 2px solid #696969; border-bottom: 0px"> ▸ <font color="# | <div class="mw-customtoggle-table04" style="width: 300px; background: #F8F8FF; border: 2px solid #696969; border-bottom: 0px"> ▸ <font color="#1F4099">'''Adult, Age <50 Years'''</font></div> | ||
<div class="mw-customtoggle-table05" style="width: 300px; background: #F8F8FF; border: 2px solid #696969; border-bottom: 0px"> ▸ <font color="# | <div class="mw-customtoggle-table05" style="width: 300px; background: #F8F8FF; border: 2px solid #696969; border-bottom: 0px"> ▸ <font color="#1F4099">'''Adult, Age >50 Years'''</font></div> | ||
<div class="mw-customtoggle-table06" style="width: 300px; background: #F8F8FF; border: 2px solid #696969; border-bottom: 0px"> ▸ <font color="# | <div class="mw-customtoggle-table06" style="width: 300px; background: #F8F8FF; border: 2px solid #696969; border-bottom: 0px"> ▸ <font color="#1F4099">'''Immunocompromised'''</font></div> | ||
<div class="mw-customtoggle-table07" style="width: 300px; background: #F8F8FF; border: 2px solid #696969"> ▸ <font color="# | <div class="mw-customtoggle-table07" style="width: 300px; background: #F8F8FF; border: 2px solid #696969"> ▸ <font color="#1F4099">'''Recurrent'''</font></div> | ||
| valign=top | | |||
{| class="wikitable mw-collapsible mw-collapsed" id="mw-customcollapsible-table01" | {| class="wikitable mw-collapsible mw-collapsed" id="mw-customcollapsible-table01" | ||
|- | |- | ||
| valign=top | | | valign=top | | ||
{| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 32em;" | {| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 32em;" | ||
! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|# | ! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#1F4099|Newborn, Age <1 Week}}'' | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ||
Line 42: | Line 44: | ||
| valign=top | | | valign=top | | ||
{| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 32em;" | {| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 32em;" | ||
! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|# | ! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#1F4099|Newborn, Age 1—4 Weeks}}'' | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ||
Line 65: | Line 67: | ||
| valign=top | | | valign=top | | ||
{| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 32em;" | {| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 32em;" | ||
! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|# | ! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#1F4099|Infant & Children}}'' | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ||
Line 81: | Line 83: | ||
| valign=top | | | valign=top | | ||
{| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 32em;" | {| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 32em;" | ||
! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|# | ! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#1F4099|Adult, Age <50 Years}}'' | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ||
Line 99: | Line 101: | ||
| valign=top | | | valign=top | | ||
{| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 32em;" | {| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 32em;" | ||
! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|# | ! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#1F4099|Adult, Age >50 Years}}'' | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ||
Line 119: | Line 121: | ||
| valign=top | | | valign=top | | ||
{| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 32em;" | {| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 32em;" | ||
! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|# | ! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#1F4099|Immunocompromised}}'' | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ||
Line 139: | Line 141: | ||
| valign=top | | | valign=top | | ||
{| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 32em;" | {| style="margin: 0 0 0em 0em; border: 0px; float: left; cellpadding=0; cellspacing= 0; width: 32em;" | ||
! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|# | ! style="padding: 0 5px; border: 0px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#1F4099|Recurrent}}'' | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ||
Line 150: | Line 152: | ||
|} | |} | ||
|} | |} | ||
|} | |||
<div class="mw-collapsible mw-collapsed"> | <div class="mw-collapsible mw-collapsed"> | ||
Line 161: | Line 163: | ||
| valign=top | | | valign=top | | ||
{| style="margin: 0 0 0em 0em; border: 1px solid #696969; float: left; width:32em" cellpadding="0" cellspacing="0"; | {| style="margin: 0 0 0em 0em; border: 1px solid #696969; float: left; width:32em" cellpadding="0" cellspacing="0"; | ||
! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|# | ! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#1F4099|Basilar Skull Fracture}}'' | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ||
Line 173: | Line 175: | ||
| valign=top | | | valign=top | | ||
{| style="margin: 0 0 0em 0em; border: 1px solid #696969; float: left; width:32em" cellpadding="0" cellspacing="0"; | {| style="margin: 0 0 0em 0em; border: 1px solid #696969; float: left; width:32em" cellpadding="0" cellspacing="0"; | ||
! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|# | ! style="padding: 0 5px; font-size: 100%; background: #F8F8FF" align=center | ''{{fontcolor|#1F4099|Head Trauma; Post-Neurosurgery}}'' | ||
|- | |- | ||
! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ! style="padding: 0 5px; font-size: 80%; background: #F5F5F5" align=left | ''Preferred Regimen'' | ||
Line 185: | Line 187: | ||
|} | |} | ||
</div></div> | </div></div> | ||
Revision as of 04:19, 20 January 2014
Meningitis Main Page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2], Sheng Shi, M.D. [3]
Empiric Therapy Adapted from Advances in treatment of bacterial meningitis. Lancet. 2012;380(9854):1693-702.[1]
Community-Acquired Meningitis ▸ Newborn, Age <1 Week
▸ Newborn, Age 1—4 Weeks
▸ Infant & Children
▸ Adult, Age <50 Years
▸ Adult, Age >50 Years
▸ Immunocompromised
▸ Recurrent
|
|
Healthcare-Associated Meningitis
|
|